Irbesartan/trichlormethiazide

Drug Profile

Irbesartan/trichlormethiazide

Alternative Names: IRTRA; IRTRA Combination Tablets HD; IRTRA Combination Tablets LD; S-474474

Latest Information Update: 24 Nov 2016

Price : $50

At a glance

  • Originator Shionogi
  • Class Antihypertensives; Biphenyl compounds; Tetrazoles
  • Mechanism of Action Angiotensin type 1 receptor antagonists; Thiazide diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 12 Sep 2014 Shionogi initiates enrolment in a phase II trial for Hypertension in Japan (UMIN000015378)
  • 04 Sep 2013 Launched for Hypertension in Japan (PO) - First global launch
  • 27 Jun 2013 Registered for Hypertension in Japan (PO) - First global approval
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top